BHI Stem Cells


Cell-based therapy is a new investigational approach that holds promise to enhance recovery from broad spectrum of diseases. Hundreds of cellular therapies are currently under investigation in clinical trials for a wide-range of medical conditions. BHI Stem Cells has conducted clinical investigations in collaboration with local partners in Slovakia and China, to evaluate the safety and efficacy of adult stem cells as a regenerative medicine for use in the treatment of chronic inflammation, musculoskeletal conditions, stroke, spinal cord injury and other medical conditions.   The studies have been conducted following approval by an Investigational Research Board and in accordance with Good Clinical Practice.